Moderna : Company in negotiations for new orders for fall of 2023 in U.S., Japan, and E.U., in addition to reiterating 2023 minimum sales expectations of approximately $5.0 billion from previously announced COVID-19 vaccine Advanced Purchase Agreements - Form 8-K

Company in negotiations for new orders for fall of 2023 in U.S., Japan, and E.U., in addition to reiterating 2023 minimum sales expectations of approximately $5.0 billion from previously... | May 4, 2023

Related Keywords

United States ,Australia ,Japan ,American ,Chris Ridley ,Lavina Talukdar ,Centers For Disease ,Exchange Commission ,Company Accolades ,American Association For Cancer Research ,Department Of Defense ,Development Expenses ,Research Development ,Corporate Development ,Group Purchasing Organizations Gpos ,Moderna Inc ,American Society Of Gene Cell Therapy ,Advanced Purchase Agreements ,Advance Purchase Agreements ,Chief Executive Officer ,Southern Hemisphere ,Northern Hemisphere ,American Association ,Cancer Research ,Propionic Acidemia ,Open Label Extension ,American Society ,Cell Therapy ,Life Edit ,Administrative Expenses ,Per Share ,Advanced Purchase ,Disease Control ,Group Purchasing Organizations ,Physician Buying Groups ,Moderna Direct ,Vaccines Day ,Purchase Agreements ,South San Francisco ,Generation Bio ,Life Edit Therapeutics ,Oriciro Genomics ,Great Place ,Great Place To Work ,Analyst Event Dates ,Webcast Information ,Months Ended March ,Stockholder Equity ,Ended December ,Private Securities Litigation Reform Act ,Annual Report ,Vice President ,Moderna ,Nc Stock Exchange ,News ,Information ,Press Release ,Company ,N ,Negotiations ,Or ,Few ,Borders ,Wall ,F ,023 ,End ,Addition ,O ,Reiterating ,Minimum ,Sales ,Expectations ,Pproximately ,Billion ,Rom Mrna Us60770k1079 ,